Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Cyanosis | Cyanosis | x | |||
| Dermatitis contact | Dermatitis contact | x | |||
| Dyspnoea | Dyspnoea | x | |||
| Oedema | Oedema | x | |||
| Dermatitis | Rash | x | x | ||
| Rash | Rash | x | x | ||
| Hypersensitivity | Hypersensitivity | x | x | ||
| Methaemoglobinaemia | Methaemoglobinaemia | x | |||
| Pruritus | Pruritus | x | x | ||
| Swelling | Swelling | x | |||
| Erythema | Erythema | x | |||
| Redness | x | ||||
| Urticaria | Urticaria | x | x | ||
| Tenderness | Tenderness | x | |||
| Respiratory distress | Respiratory distress | x | |||
| Oral discomfort | Burning mouth | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |